Organon (OGN) Accumulated Expenses (2020 - 2026)

Organon's Accumulated Expenses history runs 7 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 0.78% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $1.4 billion (up 0.78% YoY), while the FY2025 annual figure was $1.3 billion, down 5.39% from the prior year.
• Accumulated Expenses was $1.4 billion for Q1 2026 at Organon, up from $1.3 billion in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $1.5 billion in Q3 2024 to a low of $1.0 billion in Q1 2022.
• Historically, Accumulated Expenses has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2025.
• The sharpest annual moves came in 2022 and 2025: Accumulated Expenses jumped 33.6% in 2022, then slipped 5.39% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $1.2 billion in 2022, then climbed by 16.92% to $1.4 billion in 2023, then climbed by 1.58% to $1.4 billion in 2024, then fell by 5.39% to $1.3 billion in 2025, then climbed by 6.67% to $1.4 billion in 2026.
• The last three Accumulated Expenses figures came in at $1.4 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.